| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 |
| filingDate |
1998-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74b308a15b172e3388fa9dc1b5230853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e71f0bc4f20fd2751f3547dc8efac69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b676917a9402600909892d7dbd9e6eab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_046266ee57cc4665c57e5f0c968c2656
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95a45be64f5df5c7ea213ed35b0a4c15 |
| publicationDate |
2002-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1015447-B1 |
| titleOfInvention |
Piperidinylmethyloxazolidinone derivative |
| abstract |
The invention relates to the compound 5-[4-(4-fluorobenzyl) -piperidin-1-ylmethyl] -3-(4-hydroxyphenyl) -oxazolidin-2-one of formula (I), and to its physiologically suitable salts. The inventive compound acts as a neuroleptic. |
| priorityDate |
1997-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |